Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...

Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects the joints, leading to pain and disability. The introduction of biologic drugs has significantly improved ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA ... concomitant medications and illnesses, dates of studies performed ...

Drug Patients (n ... In the treatment of rheumatoid arthritis, switching among biologic agents has become established practice when patients fail to achieve a response, lose response or experience ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Without treatment, this disease can lead to serious disability. Early and aggressive treatment of rheumatoid arthritis can help prevent joint damage from inflammation. Disease-modifying anti-rheumatic ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA ... with methotrexate or other non-biologic disease-modifying antirheumatic drugs (DMARDs). The FDA’s approval ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

By limiting joint damage, disability is reduced. The primary treatment for rheumatoid arthritis is medication to reduce immune system activity and inflammation. Five categories of drugs commonly used ...

This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in ...

TNF is a key mediator in autoimmune diseases and during the last couple of decades several biologic drugs have delivered new therapeutic options for patients suffering from chronic autoimmune diseases ...